Results 171 to 180 of about 13,064 (207)
Some of the next articles are maybe not open access.

EphA2 as a target for ovarian cancer therapy

Expert Opinion on Therapeutic Targets, 2005
EphA2 is a receptor tyrosine kinase that is overexpressed by many human cancers, and is often associated with poor prognostic features. It is involved in many processes crucial to malignant progression, such as migration, invasion, metastasis, proliferation, survival and angiogenesis.
Charles N, Landen   +2 more
openaire   +2 more sources

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

Breast Cancer Research and Treatment, 2010
Overexpression and altered function of EphA2 receptor tyrosine kinase are critical in the progression of breast cancer and provide a target for breast cancer therapy. We have previously demonstrated that EphA2 overexpression decreases estrogen dependence and Tamoxifen sensitivity both in vitro and in vivo.
Yesim, Gökmen-Polar   +8 more
openaire   +2 more sources

EPHA2

2021
openaire   +1 more source

EphA2 Immunoconjugate

2012
Zhan Xiao, Dowdy Jackson, David A. Tice
openaire   +1 more source

EphA2: A Promising Therapeutic Target in Breast Cancer

Journal of Genetics and Genomics, 2021
Ceshi Chen, Dewei Jiang
exaly  

EphA2 Promotes Tumorigenicity of Cervical Cancer by Up-Regulating CDK6

Journal of Cellular and Molecular Medicine, 2021
Leilei Ding, Weijie Yuan, Zihua Chen
exaly  

EPHA2 ANTIBODIES

2022
SCHOLZ ALEXANDER   +12 more
openaire   +2 more sources

EphA2 Overexpression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma

International Journal of Cancer, 2003
Hiroyuki Kuwano   +2 more
exaly  

EPHA2 Antisense RNA Modulates EPHA2 mRNA Levels in Basal-Like/Triple-Negative Breast Cancer Cells

Biochimie, 2020
Tomoharu Sugie   +2 more
exaly  

Home - About - Disclaimer - Privacy